|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
3
|
Monk BJ, Wang J, Im S, et al: Rethinking
the use of radiation and chemotherapy after radical hysterectomy: a
clinical-pathologic analysis of a Gynecologic Oncology
Group/Southwest Oncology Group/Radiation Therapy Oncology Group
trial. Gynecol Oncol. 96:721–728. 2005. View Article : Google Scholar
|
|
4
|
Higuchi K and Hayaishi O: Enzymic
formation of D-kynurenine from D-tryptophan. Arch Biochem Biophys.
120:397–403. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamamoto S and Hayaishi O: Tryptophan
pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme
or enzymes. J Biol Chem. 242:5260–5266. 1967.PubMed/NCBI
|
|
6
|
Shimizu T, Nomiyama S, Hirata F and
Hayaishi O: Indoleamine 2,3-dioxygenase. Purification and some
properties. J Biol Chem. 253:4700–4706. 1978.PubMed/NCBI
|
|
7
|
Yoshida R, Urade Y, Tokuda M and Hayaishi
O: Induction of indoleamine 2,3-dioxygenase in mouse lung during
virus infection. Proc Natl Acad Sci USA. 76:4084–4086. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshida R and Hayaishi O: Induction of
pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection
of bacterial lipopolysaccharide. Proc Natl Acad Sci USA.
75:3998–4000. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fujigaki S, Saito K, Sekikawa K, et al:
Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is
mediated dominantly by an IFN-γ-independent mechanism. Eur J
Immunol. 31:2313–2318. 2001.PubMed/NCBI
|
|
10
|
Munn DH, Zhou M, Attwood JT, et al:
Prevention of allogeneic fetal rejection by tryptophan catabolism.
Science. 281:1191–1193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schroecksnadel K, Winkler C, Duftner C,
Wirleitner B, Schirmer M and Fuchs D: Tryptophan degradation
increases with stage in patients with rheumatoid arthritis. Clin
Rheumatol. 25:334–337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mellor AL and Munn DH: Ido expression by
dendritic cells: tolerance and tryptophan catabolism. Nat Rev
Immunol. 4:762–774. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uyttenhove C, Pilotte L, Theate I, et al:
Evidence for a tumoral immune resistance mechanism based on
tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med.
9:1269–1274. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vivier E, Tomasello E, Baratin M, Walzer T
and Ugolini S: Functions of natural killer cells. Nat Immunol.
9:503–510. 2008. View
Article : Google Scholar
|
|
15
|
Della Chiesa D, Carlomagno S, Frumento G,
et al: The tryptophan catabolite L-kynurenine inhibits the surface
expression of NKp46- and NKG2D-activating receptors and regulates
NK-cell function. Blood. 108:4118–4125. 2006.PubMed/NCBI
|
|
16
|
Inaba T, Ino K, Kajiyama H, et al:
Indoleamine 2,3-dioxygenase expression predicts impaired survival
of invasive cervical cancer patients treated with radical
hysterectomy. Gynecol Oncol. 117:423–428. 2010. View Article : Google Scholar
|
|
17
|
Ino K, Yoshida N, Kajiyama H, et al:
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for
endometrial cancer. Br J Cancer. 95:1555–1561. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takao M, Okamoto A, Nikaido T, et al:
Increased synthesis of indoleamine-2,3-dioxygenase protein is
positively associated with impaired survival in patients with
serous-type, but not with other types of, ovarian cancer. Oncol
Rep. 17:1333–1339. 2007.
|
|
19
|
Inaba T, Ino K, Kajiyama H, et al: Role of
the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the
progression of ovarian carcinoma. Gynecol Oncol. 115:185–192. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gartel AL and Kandel ES: RNA interference
in cancer. Biomol Eng. 23:17–34. 2006. View Article : Google Scholar
|
|
21
|
Scherr M and Eder M: Gene silencing by
small regulatory RNAs in mammalian cells. Cell Cycle. 6:444–449.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hannon GJ, Chubb A, Maroney PA, Hannon G,
Altman S and Nilsen TW: Multiple cis-acting elements are required
for RNA polymerase III transcription of the gene encoding H1 RNA,
the RNA component of human RNase P. J Biol Chem. 266:22796–22799.
1991.PubMed/NCBI
|
|
23
|
Walchli S and Sioud M: Vector-based
delivery of siRNAs: in vitro and in vivo challenges. Front Biosci.
13:3488–3493. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taguchi S: Establishment and
characterization of the human uterine cervical epidermoid cancer
cell line. Nippon Sanka Fujinka Gakkai Zasshi. 33:1180–1188.
1981.(In Japanese).
|
|
25
|
Ishikawa I, Nozawa S, Kikuchi K, Kurihara
S and Okumura H: Establishment of human uterine cervical cancer
cell line and comparative studies between normal and malignant
uterine cervical cells in vitro. Acta Obst Gynaec Jpn. 30:731–738.
1978.
|
|
26
|
Nozawa S, Udagawa Y, Ohta H, Kurihara S
and Fishman WH: Newly established uterine cervical cancer cell line
(SKG-III) with Regan isoenzyme, human chorionic gonadotropin
β-subunit, and pregnancy-specific β1-glycoprotein phenotypes.
Cancer Res. 43:1748–1760. 1983.PubMed/NCBI
|
|
27
|
Friedl F, Kimura I, Osato T and Ito Y:
Studies on a new human cell line (SiHa) derived from carcinoma of
uterus. I. Its establishment and morphology. Proc Soc Exp Biol Med.
135:543–545. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pattillo RA, Hussa RO, Story MT, Ruckert
ACF, Shalaby MR and Mattingly RF: Tumor antigen and human chorionic
gonadotropin in CaSKi cells: a new epidermoid cervical cancer cell
line. Science. 196:1456–1458. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morisawa T, Kuramoto H, Shimoda T,
Sakamoto I, Kato Y and Hamano M: Establishment and characterization
of a new SCC antigen producing cell line (HCS-2) from a carcinoma
of the uterine cervix. Hum Cell. 1:308–314. 1988.PubMed/NCBI
|
|
30
|
Sykes JA, Whitescarver J, Jernstrom P,
Nolan JF and Byatt P: Some properties of a new epithelial cell line
of human origin. J Natl Cancer Inst. 45:107–122. 1070
|
|
31
|
Yagita M, Huang CL, Umehara H, et al: A
novel natural killer cell line (KHYG-1) from a patient with
aggressive natural killer cell leukemia carrying a p53 point
mutation. Leukemia. 14:922–930. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takikawa O, Kuroiwa T, Yamazaki F and Kido
R: Mechanism of interferon-γ action. Characterization of
indoleamine 2,3-dioxygenase in cultured human cells induced by
interferon-γ and evaluation of the enzyme-mediated tryptophan
degradation in its anticellular activity. J Biol Chem.
263:2041–2048. 1988.
|
|
33
|
Wang d, Saga Y, Mizukami H, et al:
Indoleamine-2,3-dioxygenase (IDO), an immunosuppressive enzyme that
inhibits natural killer cell function, as a useful target for
ovarian cancer therapy. Int J Oncol. 40:929–934. 2012.PubMed/NCBI
|
|
34
|
Nakamura T, Shima T, Saeki A, et al:
Expression of indoleamine 2,3-dioxygenase and the recruitment of
Foxp3-expressing regulatory T cells in the development and
progression of uterine cervical cancer. Cancer Sci. 98:874–881.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nonaka H, Saga Y, Fujiwara H, et al:
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of
ovarian cancer through inhibition of natural killer cell function
and angiogenesis promotion. Int J Oncol. 38:113–120. 2011.
|
|
36
|
Shiota M, Ikeda Y and Wadhwa R: The
factors that contribute to the long-term expression of siRNA.
Nucleic Acids Symp Ser (Oxf). 243–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Walchli S and Sioud M: Vector-based
delivery of siRNAs: in vitro and in vivo challenges. Front Biosci.
13:3488–3493. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Serda RE, Godin B, Blanco E, Chiappini C
and Ferrari M: Multi-stage delivery nano-particle systems for
therapeutic applications. Biochim Biophys Acta. 1810:317–329. 2011.
View Article : Google Scholar : PubMed/NCBI
|
